Ladhani Maleeka, Lade Samantha, Alexander Stephen I, Baur Louise A, Clayton Philip A, McDonald Stephen, Craig Jonathan C, Wong Germaine
Sydney School of Public Health, University of Sydney, Sydney, Australia.
Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, NSW, 2145, Australia.
Pediatr Nephrol. 2017 Aug;32(8):1443-1450. doi: 10.1007/s00467-017-3636-1. Epub 2017 Mar 30.
Obesity is prevalent in children with chronic kidney disease (CKD), but the health consequences of this combination of comorbidities are uncertain. The aim of this study was to evaluate the impact of obesity on the outcomes of children following kidney transplantation.
Using data from the ANZDATA Registry (1994-2013), we assessed the association between age-appropriate body mass index (BMI) at the time of transplantation and the subsequent development of acute rejection (within the first 6 months), graft loss and death using adjusted Cox proportional hazards models.
Included in our analysis were 750 children ranging in age from 2 to 18 (median age 12) years with a total of 6597 person-years of follow-up (median follow-up 8.4 years). Overall, at transplantation 129 (17.2%) children were classified as being overweight and 61 (8.1%) as being obese. Of the 750 children, 102 (16.2%) experienced acute rejection within the first 6 months of transplantation, 235 (31.3%) lost their allograft and 53 (7.1%) died. Compared to children with normal BMI, the adjusted hazard ratios (HR) for graft loss in children who were underweight, overweight or diagnosed as obese were 1.05 [95% confidence interval (CI) 0.70-1.60], 1.03 (95% CI 0.71-1.49) and 1.61 (95% CI 1.05-2.47), respectively. There was no statistically significant association between BMI and acute rejection [underweight: HR 1.07, 95% CI 0.54-2.09; overweight: HR 1.42, 95% CI 0.86-2.34; obese: HR 1.83, 95% CI 0.95-3.51) or patient survival (underweight: HR 1.18, 95% CI 0.54-2.58, overweight: HR 0.85, 95% CI 0.38-1.92; obese: HR 0.80, 95% CI 0.25-2.61).
Over 10 years of follow-up, pediatric transplant recipients diagnosed with obesity have a substantially increased risk of allograft failure but not acute rejection of the graft or death.
肥胖在慢性肾脏病(CKD)患儿中很常见,但这种合并症组合对健康的影响尚不确定。本研究的目的是评估肥胖对肾移植术后儿童预后的影响。
利用澳大利亚和新西兰透析与移植登记处(ANZDATA Registry,1994 - 2013年)的数据,我们使用校正后的Cox比例风险模型评估了移植时年龄校正体重指数(BMI)与随后急性排斥反应(前6个月内)、移植肾失功和死亡发生之间的关联。
我们的分析纳入了750名年龄在2至18岁(中位年龄12岁)的儿童,总计随访6597人年(中位随访8.4年)。总体而言,移植时129名(17.2%)儿童被归类为超重,61名(8.1%)为肥胖。在这750名儿童中,102名(16.2%)在移植后的前6个月内发生了急性排斥反应,235名(31.3%)移植肾失功,53名(7.1%)死亡。与BMI正常的儿童相比,体重过轻、超重或被诊断为肥胖的儿童移植肾失功的校正风险比(HR)分别为1.05 [95%置信区间(CI)0.70 - 1.60]、1.03(95% CI 0.71 - 1.49)和1.61(95% CI 1.05 - 2.47)。BMI与急性排斥反应[体重过轻:HR 1.07,95% CI 0.54 - 2.09;超重:HR 1.42,95% CI 0.86 - 2.34;肥胖:HR 1.83,95% CI 0.95 - 3.51]或患者生存率[体重过轻:HR 1.18,95% CI 0.54 - 2.58,超重:HR 立0.85,95% CI 0.38 - 1.92;肥胖:HR 0.80,95% CI 0.25 - 2.61]之间无统计学显著关联。
经过10多年的随访,被诊断为肥胖的儿科肾移植受者移植肾失功的风险大幅增加,但移植肾急性排斥反应或死亡风险未增加。